Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Other Non-Current Assets: 2009-2025

Historic Other Non-Current Assets for Rockwell Medical (RMTI) over the last 17 years, with Sep 2025 value amounting to $561,000.

  • Rockwell Medical's Other Non-Current Assets rose 2.37% to $561,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $561,000, marking a year-over-year increase of 2.37%. This contributed to the annual value of $528,000 for FY2024, which is 0.19% up from last year.
  • As of Q3 2025, Rockwell Medical's Other Non-Current Assets stood at $561,000, which was down 0.00% from $561,000 recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Other Non-Current Assets ranged from a high of $729,000 in Q3 2021 and a low of $509,000 during Q2 2022.
  • Its 3-year average for Other Non-Current Assets is $536,091, with a median of $527,000 in 2024.
  • Per our database at Business Quant, Rockwell Medical's Other Non-Current Assets increased by 15.90% in 2021 and then fell by 28.40% in 2022.
  • Rockwell Medical's Other Non-Current Assets (Quarterly) stood at $619,000 in 2021, then decreased by 15.51% to $523,000 in 2022, then climbed by 0.76% to $527,000 in 2023, then rose by 0.19% to $528,000 in 2024, then climbed by 2.37% to $561,000 in 2025.
  • Its Other Non-Current Assets was $561,000 in Q3 2025, compared to $561,000 in Q2 2025 and $521,000 in Q1 2025.